How to Buy Korsana Biosciences Stock
Korsana Biosciences Inc
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics.
Korsana Biosciences stock last closed at $31.61, up 32.04% from the previous day, and has increased 91.34% in one year. It has overperformed other stocks in the Biotechnology industry by 1.06 percentage points. Korsana Biosciences stock is currently +339.88% from its 52-week low of $7.19, and -46.75% from its 52-week high of $59.36.
There are currently 668,764 KRSA shares outstanding. The market capitalization of KRSA is $21.14M. In the past 24 hours, 52,000 KRSA shares were traded.
How to Buy Korsana Biosciences Stock
Wondering how to invest in Korsana Biosciences stock? Here's how.
- Choose where to buy Korsana Biosciences stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy Korsana Biosciences stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Choose your payment method and add your info.
- Evaluate Korsana Biosciences stock: The Korsana Biosciences ticker symbol is KRSA. Is Korsana Biosciences stock a good investment? Should you buy shares of KRSA? How do KRSA's underlying business fundamentals look? Do top analysts think Korsana Biosciences is a good buy? Why has KRSA's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if KRSA is a good stock to buy).
- Place your KRSA trade: Decide if you will purchase KRSA shares at the current market price or use a limit order to purchase KRSA stock at a particular price.
- Get the latest scoop on your investment in KRSA: Create a watchlist to track your position in Korsana Biosciences stock.
Step 1: Choose where to buy Korsana Biosciences stock
You will need an online brokerage account to access the NASDAQ market and buy KRSA stock.
Our recommended brokerage: eToro
Based on our experience, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world markets: From Technology to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected your brokerage, it's time to fill out some personal info so you are able to buy KRSA stock today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to start your new trading account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have finished signing up on our top ranked stock app, you can securely and quickly fund your account:
Watch the walkthrough below to see the process of depositing funds into your brokerage account.
Step 4: Evaluate Korsana Biosciences stock
Once you have identified the best place to buy Korsana Biosciences stock, it's crucial to research their stock before you buy, so you actually understand the risk as well as the opportunity.
Korsana Biosciences Metrics
Fundamentals of KRSA
WallStreetZen was designed to help average investors do more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on KRSA's stock page.
Is KRSA stock undervalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge KRSA's intrinsic value.
Using relative valuations methods:
- KRSA could be undervalued based on its P/B ratio of 4.16x, relative to Biotechnology industry P/B ratio of 5.35x
You can access more valuation research on KRSA's stock here.
A quick look at KRSA Financials
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the KRSA balance sheet.
- KRSA has a low debt to equity ratio of 0.36.
- KRSA has $1.39M in cash and short term investments. This is sufficient to cover its annual cash burn of $4.52M.
Failed Financial Due Diligence Checks:
- KRSA profit margin has gone down from -89.5% to -353% in the past year.
- Total KRSA debt is higher than 5 years ago, relative to shareholder equity.
- KRSA has cash burn of 4517000. It does not have enough cash and short-term investments to cover this.
- There are more short-term liabilities than short-term assets on the KRSA balance sheet.
Is Korsana Biosciences stock a Buy, Hold, or Sell, according to analysts?
Out of 2 Equities analysts who give recommendations on KRSA, the consensus analyst rating on KRSA is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Korsana Biosciences stock forecast page.
KRSA Technicals
KRSA Earnings
Last year, KRSA revenue was $1.90M. During the past 5 year, KRSA's revenue has increased by -11.97% per year. This was slower than the Biotechnology industry average of 24.04%.
Learn more about KRSA's earnings and revenue performance here.
Are KRSA insiders buying or selling the stock?
Over the last year, executives and large shareholders at KRSA have bought more shares than they have sold.
Rhonda M. Chicko, CFO of KRSA, was the latest KRSA insider to buy. They bought $58,875.00 worth of KRSA shares on Aug 14, 2026.
Research more about who owns KRSA stock here.
Does KRSA stock generate passive income?
No, Korsana Biosciences doesn't provide an income stream by paying out dividends.
What do other investors have to say about KRSA?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your KRSA trade
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a specific price limit, place a limit order.
Hit the Open button and your broker will execute the order.
If you want additional assistance buying stocks on eToro, watch the how to video below:
Step 6: Get the latest scoop on your investment in KRSA
Now that you own some KRSA stock, you'll want to stay up-to-date on your company.
Put KRSA on a watchlist to keep track of your KRSA stock.
KRSA Feed
How to Buy Stock in Korsana Biosciences
To summarize, here are the 6 steps to buy Korsana Biosciences stock:
- Choose where to buy Korsana Biosciences stock
- Open a brokerage account
- Put funds into your brokerage account
- Evaluate Korsana Biosciences stock
- Place your KRSA trade
- Get the latest scoop on your investment in KRSA
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep tabs on your new investment in Korsana Biosciences, click below.
More Content You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.